“More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.

The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes.

Fifteen years ago, only one in 20 patients with advanced melanoma survived for five years, with many dying within six to nine months of the condition being confirmed.”

From The Guardian.